The Israeli pharmaceutical company Teva announced on Tuesday record profits of 1.072 billion dollars for 2005, a rise of 11 percent compared with the previous year.
The move which stunned their competitors was the purchase of Swiss company IVAX for NIS 34 billion in January.
"Today were are in an era of utilizing the human intellect - human beings' most important asset - and conditions are set for us to attain more knowledge, understanding and insight of the pharmaceutical market," said Mythological Director Eli Horrovitz, Army Radio reported.
Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>